| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |